BACKGROUND: A meta-analysis of randomized trials has shown a significant reduction of
mortality rate in patients receiving aspirin for secondary prevention after acute myocardial …

Background Acute respiratory distress syndrome (ARDS) is a life-threatening condition with
high mortality that imposes a serious medical burden. Antiplatelet therapy is a potential …

Background The present study was designed to investigate whether the prior use of aspirin
could influence the severity of the manifestation of acute coronary artery syndromes, given …

Objective—To ascertain the frequency with which paramedics follow protocols for the
administration of aspirin to patients to whom an ambulance is called for chest pain …

Background. Sepsis is characterized by dysfunctional activation of platelets, and antiplatelet
therapy could improve the outcomes of septic patients. Methods. We performed a …

Background Antiplatelet agents are commonly used for cardiovascular diseases, but their
pleiotropic effects in critically ill patients are controversial. We therefore performed a meta …

Aspirin-exacerbated respiratory disease (AERD) is a unique syndrome of airway
inflammation that frequently occurs in patients with nasal polyposis, chronic sinusitis, and …

Objective: Reducing time to reperfusion therapy is one of the goals in the management of
acute myocardial infarction (AMI). We assessed the association between timing of aspirin …

Objective: Acute respiratory distress syndrome is a common complication of critical illness,
with high mortality and limited treatment options. Preliminary studies suggest that potentially …

Background Pneumonia is complicated by high rate of mortality and cardiovascular events
(CVEs). The potential benefit of aspirin, which lowers platelet aggregation by inhibition of …